A monoclonal antibody created by the Nanobiotechnology for Diagnostics group (Nb4D) at the Institute of Advanced Chemistry of Catalonia (IQAC), part of the Spanish National Research Council (CSIC), ...

Professor Ruby Hoo Lai-chong (first, right), Department of Pharmacology and Pharmacy of HKUMed, and her research team have successfully developed a neutralising monoclonal antibody, 6H2, which targets ...

Monoclonal antibodies (mAbs) are manufactured proteins that behave similarly to antibodies found naturally in the body. Researchers initially developed them for treating certain cancers but have now ...

The FDA’s recent announcement to reduce, and in some cases replace, animal testing for monoclonal antibodies and other ...

Monoclonal antibodies target specific disease molecules. They can help treat cancer, autoimmune disorders, and infectious diseases. Discover what you should know about this therapy. Monoclonal ...

The diversity of development tools, an abundance of manufacturing options, and standardization of many unit operations has ushered in a golden age for monoclonal antibodies (mAbs). mAb process ...

Monoclonal antibodies are widely used to treat diseases ranging from cancer to autoimmune disorders. The safety and efficacy ...

Monoclonal antibodies (mAbs) have been a key therapeutic option for non-communicable diseases for decades, and a small number of mAbs have helped treat infectious diseases, including COVID-19. The ...

Monoclonal antibodies are among the most widely used biologic medicines, with applications ranging from cancer treatment to ...

Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of ...

For the first time this fall, families will be offered season-long protection for infants and some children against respiratory syncytial virus (RSV). The US Food and Drug Administration (FDA) in July ...